We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+0.64%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.26B
AUM Growth
-$618M
(-11%)
Cap. Flow
-$615M
Cap. Flow
% of AUM
-11.69%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
151
Increased
197
Reduced
368
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.8M |
| 2 |
UnitedHealth
UNH
|
+$42.1M |
| 3 |
Verizon
VZ
|
+$32.3M |
| 4 |
Comcast
CMCSA
|
+$29.1M |
| 5 |
Citigroup
C
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$70.8M |
| 2 |
Apple
AAPL
|
+$38.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$36.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.88% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
New Jersey Resources
NJR
$6.06B
| $200K | ﹤0.01% |
+7,270
| New | +$217K |
|
727
QuinStreet
QNST
$870M
| $200K | ﹤0.01% |
30,958
-5,300
| -15% | -$31.2K |
|
|
CHS
728
DELISTED
Chicos FAS, Inc.
CHS
| $198K | ﹤0.01% |
11,920
-58,930
| -83% | -$1M |
|
729
Capital City Bank Group
CCBG
$882M
| $197K | ﹤0.01% |
+12,913
| New | +$194K |
|
|
HTB
730
HomeTrust Bancshares
HTB
$818M
| $188K | ﹤0.01% |
+11,213
| New | +$179K |
|
|
MRVC
731
DELISTED
MRV Communications Inc
MRVC
| $187K | ﹤0.01% |
15,313
| – | – |
|
732
FNB Corp
FNB
$6.78B
| $185K | ﹤0.01% |
12,900
| – | – |
|
733
Inseego
INSG
$108M
| $184K | ﹤0.01% |
5,669
-9,486
| -63% | -$459K |
|
734
Minerva Neurosciences
NERV
$188M
| $182K | ﹤0.01% |
+3,925
| New | +$167K |
|
|
UMPQ
735
DELISTED
Umpqua Holdings Corp
UMPQ
| $180K | ﹤0.01% |
10,000
-1,590
| -14% | -$28.1K |
|
|
TE
736
DELISTED
TECO ENERGY INC
TE
| $178K | ﹤0.01% |
10,080
| – | – |
|
|
SPRT
737
DELISTED
support.com, Inc.
SPRT
| $177K | ﹤0.01% |
41,833
-30,667
| -42% | -$140K |
|
738
Universal Technical Institute
UTI
$2.08B
| $174K | ﹤0.01% |
20,200
+3,600
| +22% | +$32.5K |
|
739
Ampco-Pittsburgh
AP
$167M
| $171K | ﹤0.01% |
+11,303
| New | +$183K |
|
740
Cumberland Pharmaceuticals
CPIX
$99M
| $171K | ﹤0.01% |
23,960
-10,300
| -30% | -$71.6K |
|
741
Neurogene
NGNE
$696M
| $171K | ﹤0.01% |
+1,231
| New | +$187K |
|
|
PCMI
742
DELISTED
PCM, Inc
PCMI
| $170K | ﹤0.01% |
16,957
-9,790
| -37% | -$96.7K |
|
|
NXGN
743
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $169K | ﹤0.01% |
+10,200
| New | +$164K |
|
|
INWK
744
DELISTED
InnerWorkings, Inc.
INWK
| $167K | ﹤0.01% |
25,004
-4,000
| -14% | -$26.1K |
|
|
SMRT
745
DELISTED
Stein Mart Inc
SMRT
| $167K | ﹤0.01% |
15,904
| – | – |
|
|
DALN
746
DELISTED
DallasNews
DALN
| $165K | ﹤0.01% |
7,355
-7,327
| -50% | -$192K |
|
|
MEET
747
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $160K | ﹤0.01% |
+94,000
| New | +$154K |
|
|
WIBC
748
DELISTED
WILSHIRE BANCORP INC
WIBC
| $160K | ﹤0.01% |
12,700
-500
| -4% | -$5.55K |
|
|
SYNC
749
DELISTED
Synacor, Inc.
SYNC
| $159K | ﹤0.01% |
98,579
| – | – |
|
|
STML
750
DELISTED
Stemline Therapeutics, Inc.
STML
| $158K | ﹤0.01% |
+13,400
| New | +$186K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2015 Portfolio in Review
As of Q2 2015, Jacobs Levy Equity Management held 928 positions worth $5.26B, down 11% from $5.88B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jacobs Levy Equity Management withdrew a net $615M in Q2 2015, closing 132 positions and reducing 368 holdings. Its most notable exit was BROADCOM CORP CL-A, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jacobs Levy Equity Management opened a new position in UnitedHealth worth $43.4M.
- Jacobs Levy Equity Management's largest Q2 2015 buy was UnitedHealth: 355,991 shares worth $43.4M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q2 2015, an estimated $43.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2015 reduction was Microsoft, cutting an estimated $70.8M.
- Jacobs Levy Equity Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $31.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 14% of its $5.26B portfolio in Q2 2015.
- Jacobs Levy Equity Management opened 151 new positions and closed 132 in Q2 2015.
- Jacobs Levy Equity Management's portfolio value fell 11% quarter-over-quarter to $5.26B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2015, filed 14 Aug 2015.